Future Performance Will Reflect Stable Outlook and Completed Share Repurchase Program

AN

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

26 Feb 25

Updated

12 Nov 25

Views

47

12 Nov

US$24.72

AnalystConsensusTarget's Fair Value

US$22.67

9.1% overvalued

1Y

7.9%

7D

0.04%

Loading

1Y

7.9%

7D

0.04%

You can edit this narrative until Nov 13 7:10 AM. Then, changes will post as Updates.

Author's Valuation

US$22.679.1% overvalued

AnalystConsensusTarget Fair Value

Shared on 12 Nov 25

PRA: Margins Will Improve While Revenue Pressures And Fair Value Persist

Analysts have modestly adjusted their price target for ProAssurance, maintaining it at $22.67. Updated forecasts reflect slightly higher discount rates, a softer revenue outlook, improved profit margins, and a marginally lower future price-to-earnings ratio.

1 view

Shared on 29 Oct 25

Analysts have slightly adjusted their price target for ProAssurance, maintaining a fair value estimate of $22.67 while taking into account a marginally lower outlook for revenue growth and profit margins. What's in the News ProAssurance reported it repurchased zero shares between April 1, 2025 and June 30, 2025, resulting in no additional spending on buybacks in this period (Key Developments).

3 views

Shared on 14 Oct 25

Fair value Decreased 9.33%

Analysts have lowered their price target for ProAssurance from $25.00 to $22.67. This change reflects revised expectations around the company’s fair value based on recent financial performance.

2 views

Shared on 23 Sep 25

Fair value Increased 10%

Upward revisions in ProAssurance's consensus revenue growth forecasts and higher future P/E expectations have contributed to a significant increase in the fair value estimate, with the analyst price target rising from $22.67 to $25.00. What's in the News ProAssurance has completed the repurchase of 12,758,534 shares (22.5%) for $490.42 million under the buyback announced in 2011, with no shares repurchased from April 1, 2025 to June 30, 2025.

1 view

Shared on 19 Mar 25

Fair value Increased 26%

0 views

Shared on 13 Mar 25

Fair value Decreased 20%

AnalystConsensusTarget has decreased revenue growth from -3.4% to -2.2% and decreased future PE multiple from 22.1x to 19.6x.

1 view

Valuator

Company Info

Notes

AnalystConsensusTarget Fair Value

US$22.67

9.1% overvalued

Future estimation in

Revenue

Profit Margin

Future PE

Growth p.a.

%

Decrease

Increase

Forecast revenue growth rate

-2.82%

Historical revenue growth rate

1.85%

Insurance revenue growth rate

0.28%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

7.11%

Calculation

US$72.43m

Earnings '28

x

19.91x

PE Ratio '28

=

US$1.44b

Market Cap '28

US$1.44b

Market Cap '28

/

52.19m

No. shares '28

=

US$27.63

Share Price '28

US$27.63 Share Price '28

Discounted to 2025 @ 6.96% p.a.

=

US$22.58

Fair Value '25